×
China Cord Blood Total Assets 2010-2022 | CORBF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
China Cord Blood total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
China Cord Blood Total Assets 2010-2022 | CORBF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
China Cord Blood total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$146.1B
CVS Health (CVS)
$78.8B
Elevance Health (ELV)
$66.1B
Cencora (COR)
$56.6B
DiDi Global (DIDIY)
$24.2B
Labcorp Holdings (LH)
$22.1B
Natera (NTRA)
$19.2B
BioMerieux (BMXMF)
$17.1B
EUROFINS SCIENT (ERFSF)
$14.9B
ICON (ICLR)
$14.7B
CochLear (CHEOY)
$13.3B
Solventum (SOLV)
$12.6B
Medpace Holdings (MEDP)
$12.3B
Revvity (RVTY)
$10.7B
Viatris (VTRS)
$10.6B
Avantor (AVTR)
$9.4B
Sonic Healthcare (SKHHY)
$8.9B
Charles River Laboratories (CRL)
$8.7B
HealthEquity (HQY)
$8.5B
Caris Life Sciences,�Inc (CAI)
$7.5B
Bausch + Lomb (BLCO)
$4.9B
Amplifon S.p.A (AMFPF)
$3.9B
BrightSpring Health Services (BTSG)
$3.7B
Sotera Health (SHC)
$3.4B
GeneDx Holdings (WGS)
$3B
Surgery Partners (SGRY)
$2.9B
Concentras Parent (CON)
$2.6B
Organon (OGN)
$2.6B
Alignment Healthcare (ALHC)
$2.6B
Progyny (PGNY)
$2B